As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Catalyst Pharma ( ($CPRX) ) has shared an announcement. On August 25, 2025, Catalyst Pharmaceuticals and its licensor SERB S.A. announced a ...

Catalyst Pharmaceuticals ( NASDAQ: CPRX) said that the company and licensor SERB S.A. signed a settlement agreement with ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

Pharma companies are separating consumer healthcare businesses to drive growth, facing challenges in a competitive market.

This isn’t some fever dream induced by too much sunshine – it’s one of Florida’s most spectacular roadside attractions, a bronze behemoth that has become an unlikely pilgrimage site for travelers ...

We’ve rounded up the top four most dangerous species below. Introduced in Harry Potter and the Chamber of Secrets, the ...

The Harry Potter HBO show has the opportunity to highlight some of the darker elements of the Wizarding World.

Despite ending in 2021, Money Heist has become a global sensation on Netflix, racking up over 100 million viewing hours in ...

A s fans patiently wait for the return of Omay Sy's Assane Diop in Lupin Season 4, Netflix has given little to no updates ...

Driven by increasing consumer demand for allergen-friendly, high-protein, and gut-health-supporting alternatives, lupin milk ...